Skip to main content

Eisai Value Stock - Dividend - Research Selection

Eisai Co., Ltd.

ISIN: JP3160400002, WKN: 855526

Market price date: 24.05.2021
Market price: 7.012,00 JPY




Eisai Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 18-05-2021
Cash flow
Net operating cash flow 73.853.000.000
Capital Expenditures -19.148.000.000
Free cash flow 54.705.000.448
Balance sheet
Total Equity 727.942.000.000
Liabilities & Shareholders equity 1.090.010.000.000
Income statement
Net income 42.119.000.000
Eps (diluted) 146,900
Diluted shares outstanding 286.710.000
Net sales/revenue 645.942.000.000

Fundamental ratios calculated on: 24-05-2021

Ratios
Key figures 24-05-2021
Cash flow
P/C 27,22
   
P/FC 36,75
Balance sheet
ROI3,86
ROE66,78
Income statement
P/E47,73
Div. Yield2,28%
P/B2,76
P/S3,11


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4523.TSE
Market Capitalization19.382.681.600,00 USD
Country
IndicesNIKKEI 225
Sectors
Raw Data SourceIFRS in Millionen JPY
Stock Split
Internetwww.eisai.co.jp


Description of the company

Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's businesses include pharmaceutical business and other business. The Company's segments include Japan (Prescription Medicines, Generics and Diagnostics), Americas (North America, Central and South America), China, Asia (South Korea, Taiwan, Hong Kong, India and ASEAN), EMEA (Europe, the Middle East, Africa and Oceania) and Consumer Healthcare Business-Japan. The Company offers products, which include Halaven, Aricept, Aloxi, Fycompa, Lenvima, Methycobal, BELVIQ, Pariet, LYRICA, HUMIRA, Lunesta, E5501/AKR-501, BAN2401, Chocola BB Products, E2609 and E2006. The Company's consumer healthcare brand containing Vitamin B is Chocola BB Products. The Company offers a range of products, including Chocola BB Plus, a Vitamin B2 preparation for rough skin and stomatitis, and nutritional supplements and energy drinks, which are available for healthcare needs.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.eisai.co.jp